Log in
Enquire now
‌

US Patent 11339170 Spiropyrrolidine derived antiviral agents

Patent 11339170 was granted and assigned to Enanta Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Current Assignee
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
113391700
Patent Inventor Names
Ruichao Shen0
Guoqiang Wang0
Hui Cao0
Jiajun Zhang0
Jorden Kass0
Wei Li0
Xiaowen Peng0
Xuri Gao0
...
Date of Patent
May 24, 2022
0
Patent Application Number
174794550
Date Filed
September 20, 2021
0
Patent Citations
‌
US Patent 10221396 Reprogramming T cells and hematopoietic cells
‌
US Patent 10260048 Generation of induced pluripotent stem cells from small volumes of peripheral blood
‌
US Patent 10383929 BCMA chimeric antigen receptors
‌
US Patent 10428142 Multipartite signaling proteins and uses thereof
‌
US Patent 10457731 Multipartite signaling proteins and uses thereof
‌
US Patent 10472618 Histidyl-tRNA synthetase-Fc conjugates
‌
US Patent 10479975 Methods of making T cell compositions
‌
US Patent 10590084 Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
...
Patent Citations Received
‌
US Patent 11858945 Alkyne-containing antiviral agents
0
‌
US Patent 12006291 Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid
0
‌
US Patent 11993600 Saturated spirocyclics as antiviral agents
0
‌
US Patent 11976084 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11970502 Macrocyclic antiviral agents
0
‌
US Patent 11919910 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11912714 Spiropyrrolidine derived antiviral agents
0
Patent Primary Examiner
‌
Jean P Cornet
0
CPC Code
‌
A61K 31/4164
0
‌
A61K 31/421
0
‌
A61K 31/426
0
‌
A61K 31/439
0
‌
A61K 31/44
0
‌
A61K 31/4402
0
‌
A61K 31/4409
0
‌
A61K 31/4425
0
...
Patent abstract

The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11339170 Spiropyrrolidine derived antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.